Janney Montgomery Scott
BMY.RT

Janney Montgomery Scott’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Janney Montgomery Scott’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-49,856
Closed -$34K – 2439
2020
Q4 		$34K Sell
49,856
-30,518
-38% -$65K ﹤0.01% 2211
2020
Q3 		$181K Sell
80,374
-37,660
-32% -$108K ﹤0.01% 1931
2020
Q2 		$423K Sell
118,034
-16,988
-13% -$61.3K ﹤0.01% 1446
2020
Q1 		$513K Sell
135,022
-18,488
-12% -$60.9K ﹤0.01% 1210
2019
Q4 		$462K Buy
+153,510
New +$399K ﹤0.01% 1456

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

Janney Montgomery Scott's BMY.RT Position: Q1 2021 in Review

Janney Montgomery Scott sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 49,856 shares — an estimated $34K sold.

Janney Montgomery Scott first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $513K in Q1 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Janney Montgomery Scott reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Janney Montgomery Scott sold 49,856 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $34K.
  • Janney Montgomery Scott first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • Janney Montgomery Scott's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $513K in Q1 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Janney Montgomery Scott's 13F filing for Q1 2021, filed 27 Apr 2021.